610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827764926505025536 |
|---|---|
| author | Shailender Bhatia Ramesh Rengan Sylvia M Lee Scott S Tykodi Jing Zeng Mary Redman Peter H Goff Kelsey K Baker |
| author_facet | Shailender Bhatia Ramesh Rengan Sylvia M Lee Scott S Tykodi Jing Zeng Mary Redman Peter H Goff Kelsey K Baker |
| author_sort | Shailender Bhatia |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:12:47Z |
| format | Article |
| id | doaj.art-be0ed318d898496dbd1c082506d1fcd6 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:12:47Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-be0ed318d898496dbd1c082506d1fcd62023-11-11T19:30:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0610610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinomaShailender Bhatia0Ramesh Rengan1Sylvia M Lee2Scott S Tykodi3Jing Zeng4Mary Redman5Peter H Goff6Kelsey K Baker71University of Washington, Seattle, WA, USAAff2 grid.34477.330000000122986657Department of Radiation OncologyUniversity of Washington School of Medicine Seattle WA USAAff1 grid.270240.30000000121801622Clinical Research DivisionD3-100 Fred Hutchinson Cancer Research Center 1100 Fairview Ave 98109 Seattle WA USA1University of Washington, Seattle, WA, USADepartment of Chronic Noncommunicable Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan, China4Fred Hutchinson Cancer Research Center, Seattle, WA, United States1University of Washington, Seattle, WA, USA2Fred Hutchinson Cancer Center, Seattle, WA, USA |
| spellingShingle | Shailender Bhatia Ramesh Rengan Sylvia M Lee Scott S Tykodi Jing Zeng Mary Redman Peter H Goff Kelsey K Baker 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma Journal for ImmunoTherapy of Cancer |
| title | 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma |
| title_full | 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma |
| title_fullStr | 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma |
| title_full_unstemmed | 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma |
| title_short | 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma |
| title_sort | 610 immunorad a stratified phase ii trial of image guided hypofractionated radiotherapy with concurrent nelfinavir pd 1 inhibition in advanced melanoma lung cancer renal cell carcinoma |
| work_keys_str_mv | AT shailenderbhatia 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT rameshrengan 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT sylviamlee 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT scottstykodi 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT jingzeng 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT maryredman 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT peterhgoff 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma AT kelseykbaker 610immunoradastratifiedphaseiitrialofimageguidedhypofractionatedradiotherapywithconcurrentnelfinavirpd1inhibitioninadvancedmelanomalungcancerrenalcellcarcinoma |